# Desvenlafaxine Succinate

NDC: 33342-388
Generic name: Desvenlafaxine Succinate
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20200730

FDA application: ANDA211427

## Active ingredients

- DESVENLAFAXINE SUCCINATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-388"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-388
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=edf18b33-a226-44f8-9f42-c409e691ee64